|
CT Value
|
EIA Toxin Positive a
|
Total EIA b
|
Mortality/month c
|
Mortality/3 months c
|
|---|
|
18
|
1 (100%)
|
1
|
1
|
1
|
|
19
|
4 (80%)
|
5
|
2
|
2
|
|
20
|
32 (84%)
|
38
|
7
|
12
|
|
21
|
80 (85%)
|
94
|
17
|
25
|
|
22
|
113 (80%)
|
140
|
16
|
29
|
|
23
|
119 (72%)
|
166
|
23
|
31
|
|
24
|
106 (67%)
|
157
|
27
|
39
|
|
25
|
96 (56%)
|
171
|
21
|
34
|
|
26
|
63 (50%)
|
125
|
12
|
19
|
|
27
|
52 (37%)
|
139
|
19
|
34
|
|
28
|
24 (27%)
|
89
|
7
|
13
|
|
29
|
23 (24%)
|
95
|
10
|
16
|
|
30
|
17 (20%)
|
83
|
8
|
16
|
|
31–37
|
24 (7%)
|
347
|
41
|
60
|
|
All
|
754 (46%)
|
1650
|
210
|
331
|
|
18–25
|
551 (72%)
|
772
|
113
|
173
|
|
26–37
|
203 (23%)
|
878
|
97
|
158
|
-
a All samples are GDH, NAAT and toxin A and B EIA positive
-
b Total number of toxin A and B EIAs undertaken from GDH and NAAT positive samples including both negative and positive results for toxin A and B
-
c Reflects the number of patients with 1 month or 3-month mortality
